Chickasaw Capital Management LLC Gilead Sciences, Inc. Transaction History

Chickasaw Capital Management LLC

  • $2.47 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 11, 2019
SELL
$60.54 - $79.0 $1.37 Million - $1.79 Million
-22,600 Closed
0 $0
Q2 2018

Jul 23, 2018
BUY
$64.88 - $75.68 $32,439 - $37,840
500 Added 2.26%
22,600 $1.6 Million
Q3 2017

Oct 16, 2017
BUY
$72.11 - $85.47 $1.59 Million - $1.89 Million
22,100
22,100 $1.79 Million

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Chickasaw Capital Management LLC Portfolio

Follow Chickasaw Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chickasaw Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chickasaw Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email